Table 1.

Comparison of clinical characteristics between the high Ki-67 expression group and low Ki-67 expression group.

Variables	High Ki-67 Group	Low Ki-67 Group	P
Age(year)	63.89 ± 10.96	66.43 ± 10.96	0.217
Sex			0.454
Male	49	43
Female	16	10
HBsAg			0.712
Positive	45	35
Negative	20	18
AFP (mg/mL)	2482.87 ± 11223.84	845.03 ± 4714.03	0.327
Alb (g/L)	38.61 ± 4.53	38.87 ± 4.09	0.746
ALT(IU/L)	38.24 ± 37.42	40.53 ± 36.98	0.743
AST(IU/L)	42.58 ± 46.88	46.16 ± 38.91	0.66
TBIL (µmol/L)	17.96 ± 20.1	16.2 ± 8.75	0.558
DBIL (µmol/L)	6.18 ± 11.42	6.12 ± 5.08	0.971
PT (s)	13.11 ± 1.42	13.17 ± 1.34	0.806
INR	1.05 ± 0.14	1.06 ± 0.11	0.664
Tumor Size(cm)	4.85 ± 2.77	5.0 ± 2.85	0.769
Cirrhosis			0.259
Absent	30	30
Present	35	23
Multifocality			0.371
Absent	51	45
Present	14	8

AFP, alpha fetoprotein; ALB, albumin level; ALT, alanine aminotransferase; AST, aspartate aminotransferase; TBIL, total bilirubin; DBIL, directed bilirubin; PT, prothrombin time; INR, international normalized ratio.

Multifocality absent means only one tumor lesion (51 cases in the High Ki-67 group and 45 cases in the Low Ki-67 group), multifocality present means there are multiple tumor lesions (14 cases in the High Ki-67 group and 8 in the Low Ki-67 group).